Above all, serum LDH, CEA, and CYF21-1 are valuable and sensitive serum makers for the evaluation of disease activity of PAP and may reflect the response to various treatment of PAP. The gene discussed is CEACAM5; the disease is pulmonary alveolar proteinosis.